Video News November 8, 2021Regeneron says single dose of Covid antibody cocktail provides long-term protection 0 0 Share
Press Release November 8, 2021New Phase 3 Analyses Show That a Single Dose of REGEN-COV® (casirivimab and imdevimab) Provides Long-term Protection Against COVID-19 0 0 Share
Company Ticker News November 8, 2021Regeneron says its COVID-19 antibody cocktail can prevent COVID-19 infections for months 0 0 Share
Company Ticker News November 5, 20213 Reasons Why Investors Should Love Regeneron's Q3 Update 0 0 Share
Company Ticker News November 4, 2021Regeneron earnings boosted by $804 million in sales of COVID antibody treatment 0 0 Share
Company Ticker News November 4, 2021Regeneron quarterly profit nearly doubles on strong demand for eczema drug 0 0 Share
Company Ticker News November 4, 2021Regeneron Reports Third Quarter 2021 Financial and Operating Results 0 0 Share
Company Ticker News November 3, 2021Is Regeneron Pharmaceuticals (REGN) Outperforming Other Medical Stocks This Year? 0 0 Share
